Inhibition of TGF-β in the late post-MI period attenuated cardiac remodeling and interstitial fibrosis, while inhibition of TGF-β in the early post-MI period resulted in disruption of myocardial healing [4] and an increased risk of cardiac rupture [32]. The gene discussed is TGFB1; the disease is myocardial infarction.